Evidence map›Paper›PMID 39723537›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2025

High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.

Tsutomu Shinohara, Jan-Renier Moonen, Yoon Hong Chun, Yannick C Lee-Yow, Kenichi Okamura, Jason M Szafron, Jordan Kaplan, Aiqin Cao, Lingli Wang, Divya Guntur and 14 more

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Endothelial Continuum and Capillary Specialization in Pulmonary Vascular Development.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Endothelial Heterogeneity in Pulmonary Hypertension.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  13. Current Evidence on the Potential Role of EndothelialReviews in cardiovascular medicine · 2026
    Review
  14. Review
  15. Review
  16. Endothelial to mesenchymal transition: a central mechanism in diabetes-induced vascular pathology.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Review
  17. From development to regeneration: the endothelial interface in lung injury and repair.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  18. Article
  19. Article
  20. Fluid Shear Stress-Regulated Vascular Remodeling: Past, Present, and Future.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Tsutomu Shinohara *Department of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0002-0697-5568
Jan-Renier Moonen *Department of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0002-0361-824X
Yoon Hong ChunDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0002-9871-5244
Yannick C Lee-YowBasic Science and Engineering Initiative, Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital (T.S., J.-R.M., Y.C.L.-Y., J. Kaplan, A.C., L.W., S.T., S.I., K.G., J.M.E., M.R.), Stanford University School of Medicine, CA.ORCID 0000-0002-9642-9121
Kenichi OkamuraStanford Cardiovascular Institute (T.S., J.-R.M., Y.H.C., K.O., J.M.S., J. Kaplan, A.C., L.W., S.T., S.I., M.D., A.L.M., J.M.E., M.R.), Stanford University School of Medicine, CA.ORCID 0000-0001-9205-3457
Jason M SzafronDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).
Jordan KaplanDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0002-2288-2556
Aiqin CaoDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).
Lingli WangDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).
Divya GunturDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).
Shalina TaylorDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).
Sarasa IsobeDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0002-7405-0903
Melody DongDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0001-7791-5012
Weiguang YangDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0003-3324-4346
Katherine GuoBasic Science and Engineering Initiative, Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital (T.S., J.-R.M., Y.C.L.-Y., J. Kaplan, A.C., L.W., S.T., S.I., K.G., J.M.E., M.R.), Stanford University School of Medicine, CA.
Benjamin D FrancoDepartment of Comparative Medicine (B.D.F., C.P.), Stanford University School of Medicine, CA.
Cholawat PacharinsakDepartment of Comparative Medicine (B.D.F., C.P.), Stanford University School of Medicine, CA.
Laura J PisaniDepartment of Radiology, Stanford University School of Medicine, CA (L.J.P.).ORCID 0000-0003-3084-3300
Shinji SaitohDepartment of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Japan (S.S.).ORCID 0000-0001-6911-3351
Yoshihide MitaniDepartment of Pediatrics, Mie University Graduate School of Medicine, Japan (Y.M.).ORCID 0000-0002-6038-8161
Alison L MarsdenDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0003-1902-171X
Jesse M EngreitzStanford Cardiovascular Institute (T.S., J.-R.M., Y.H.C., K.O., J.M.S., J. Kaplan, A.C., L.W., S.T., S.I., M.D., A.L.M., J.M.E., M.R.), Stanford University School of Medicine, CA.ORCID 0000-0002-5754-1719
Jakob KörbelinDepartment of Oncology, Hematology and Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Germany (J. Körbelin).ORCID 0000-0002-5435-7182
Marlene RabinovitchDepartment of Pediatrics (T.S., J.-R.M., Y.H.C., J.M.S., J. Kaplan, A.C., L.W., D.G., S.T., S.I., M.D., W.Y., A.L.M., M.R.).ORCID 0000-0001-7886-7104

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
The Cellular Response to Elafin in PAHP01HL108797 · NHLBI · STANFORD UNIVERSITY · PI RABINOVITCH, MARLENE · 2011 to 2021
$19.7M
Pulmonary Hypertension in Genetically Modified MiceR01HL074186 · NHLBI · STANFORD UNIVERSITY · PI RABINOVITCH, MARLENE · 2004 to 2022
$10.4M
Pulmonary Hypertension Breakthrough InitiativeR24HL123767 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ALDRED, MICHEALA A, ERZURUM, SERPIL C. · 2014 to 2017
$10.1M
T32 Training Program in Mechanisms and Innovation in Vascular DiseaseT32HL098049 · NHLBI · STANFORD UNIVERSITY · PI Nicholas James Leeper, Philip S Tsao · 2010 to 2026
$6.3M
Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause EndMT and PAHR01HL138473 · NHLBI · STANFORD UNIVERSITY · PI Mark Robert Nicolls, Marlene Rabinovitch · 2017 to 2026
$4.9M
Stanford Training Program in Lung BiologyT32HL129970 · NHLBI · STANFORD UNIVERSITY · PI CORNFIELD, DAVID N., NICOLLS, MARK ROBERT · 2016 to 2025
$3.2M
High Shear Stress Alters Gene Regulation in Pulmonary Arterial HypertensionR01HL152134 · NHLBI · STANFORD UNIVERSITY · PI RABINOVITCH, MARLENE · 2021 to 2024
$2.9M
Mapping enhancer-gene regulation in single cells to connect genetic variants to target genes and cell typesR35HG011324 · NHGRI · STANFORD UNIVERSITY · PI ENGREITZ, JESSE M · 2020 to 2024
$2.3M
Systematic mapping and prediction of gene-enhancer connectionsR00HG009917 · NHGRI · STANFORD UNIVERSITY · PI ENGREITZ, JESSE M · 2020 to 2022
$796k
Vevo LAZR Photoacoustic and Ultrasound Imaging SystemS10OD010344 · OD · STANFORD UNIVERSITY · PI GAMBHIR, SANJIV S · 2013 to 2013
$522k
Upgrade of the Stanford GE-Varian Experimental MRI Scanner to the Current Model MS10RR026917 · NCRR · STANFORD UNIVERSITY · PI MOSELEY, MICHAEL E · 2010 to 2010
$497k
American Heart Association-American Stroke Association 20POST35080009 - SARASA ISOBENCRR NIH HHS S10 RR026917NCRR NIH HHS UL1 RR024986NHGRI NIH HHS K99 HG009917NHGRI NIH HHS R00 HG009917NHGRI NIH HHS R35 HG011324NHLBI NIH HHS P01 HL108797NHLBI NIH HHS R01 HL074186NHLBI NIH HHS R01 HL138473NHLBI NIH HHS R01 HL152134NHLBI NIH HHS R24 HL123767NHLBI NIH HHS T32 HL098049NHLBI NIH HHS T32 HL129970NIH HHS S10 OD010344
6 · The paper itself

Abstract

backgroundComputational modeling indicated that pathological high shear stress (HSS; 100 dyn/cm

methodsWe used the Ibidi perfusion system to determine whether HSS applied to human PA endothelial cells (ECs) induces EndMT when compared with physiological laminar shear stress (15 dyn/cm

resultsEndMT, a feature of PAH not previously attributed to HSS, was observed. HSS did not alter the induction of transcription factors KLF (Krüppel-like factor) 2/4, but an ERG (ETS-family transcription factor) was reduced, as were histone H3 lysine 27 acetylation enhancer-promoter peaks containing ERG motifs. Consequently, there was reduced interaction between ERG and KLF2/4, a feature important in tethering KLF and the chromatin remodeling complex to DNA. In PA ECs under laminar shear stress, reducing ERG by siRNA caused EndMT associated with decreased BMPR2 (bone morphogenetic protein receptor 2), CDH5 (cadherin 5), and PECAM1 (platelet and EC adhesion molecule 1) and increased SNAI1/2 (Snail/Slug) and ACTA2 (smooth muscle α2 actin). In PA ECs under HSS, transfection of ERG prevented EndMT. HSS was then induced in mice by an aortocaval shunt, causing progressive PAH over 8 weeks. An adeno-associated viral vector (AAV2-ESGHGYF) was used to replenish ERG selectively in PA ECs. Elevated PA pressure, EndMT, and vascular remodeling (muscularization of peripheral arteries) in the aortocaval shunt mice were markedly reduced by ERG delivery.

conclusionsPathological HSS reduced lung EC ERG, resulting in EndMT and PAH. Agents that upregulate ERG could reverse HSS-mediated PAH and occlusive vascular remodeling resulting from high flow or narrowed PAs.

Indexed as

Arterial PressureEndothelial CellsEpithelial-Mesenchymal TransitionHypertension, PulmonaryMechanotransduction, CellularPulmonary Arterial HypertensionPulmonary ArteryAnimalsAntigens, CDArteriovenous Shunt, SurgicalBone Morphogenetic Protein Receptors, Type IICadherin 5CadherinsCells, CulturedDisease Models, AnimalEndothelial-Mesenchymal TransitionAntigens, CDBone Morphogenetic Protein Receptors, Type IICadherin 5CadherinsERG protein, humanERG protein, mouseKLF2 protein, humanKlf2 protein, mouseKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsOncogene ProteinsSnail Family Transcription FactorsTranscriptional Regulator ERGaorto-caval shunt miceendothelial cellsendothelial-mesenchymal transitionERGpulmonary arterial hypertensionshear stress

Identifiers

PMID39723537
PMCPMC11753934

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.